Primary Mast Cell Sarcoma of the Maxillary Sinus and Gingiva Mimicking Malignant Neuroendocrine Tumor: A Case Report.


Journal

Head and neck pathology
ISSN: 1936-0568
Titre abrégé: Head Neck Pathol
Pays: United States
ID NLM: 101304010

Informations de publication

Date de publication:
15 Oct 2024
Historique:
received: 20 08 2024
accepted: 10 09 2024
medline: 15 10 2024
pubmed: 15 10 2024
entrez: 15 10 2024
Statut: epublish

Résumé

Mast cell sarcoma (MCS) is an extremely rare and aggressive malignancy primarily affecting bones, with limited literature associating it with neuroendocrine marker expression. This report presents a rare case of MCS arising in the maxillary sinus and gingiva. A 74-year-old man presented with a progressively enlarging ulcer on the right-sided upper gingiva. Magnetic resonance imaging revealed a 3.4 cm tumor on the floor of the right maxillary sinus. The patient underwent an inferior maxillectomy and right-sided neck dissection. Microscopically, the tumor consisted of monotonous round cells with oval nuclei, vesicular chromatin, inconspicuous nucleoli, and brisk mitoses. A panel of immunohistochemical stains was initially applied to exclude common sinonasal undifferentiated neoplasms, such as sinonasal undifferentiated carcinoma, melanoma, rhabdomyosarcoma, Ewing sarcoma, and lymphoma. The tumor cells showed patchy staining for INSM1 and synaptophysin, but were negative for AE1/AE3, CAM5.2, p40, chromogranin, S100, HMB45, NKX2.2, desmin, CD45 (LCA), CD3, and CD20, with intact INI1 and BRG1 expression. No specific diagnosis could be rendered based on the staining results, leading to consideration of other rare malignancies. Additional staining revealed positivity for CD117, mast cell tryptase, CD13, CD33, CD43, and CD68, confirming the MCS diagnosis. Molecular testing for KIT mutation was negative. Subsequent bone marrow biopsy demonstrated infiltration of atypical mast cells, which led to a diagnosis of mast cell leukemia. Despite high-dose chemotherapy, the patient died three months after the initial diagnosis. The undifferentiated epithelioid morphology and unusual aberrant neuroendocrine marker expression posed significant diagnostic challenges. The major differential diagnoses were discussed in this report.

Identifiants

pubmed: 39404971
doi: 10.1007/s12105-024-01702-w
pii: 10.1007/s12105-024-01702-w
doi:

Substances chimiques

Biomarkers, Tumor 0
Homeobox Protein Nkx-2.2 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

97

Informations de copyright

© 2024. The Author(s).

Références

Matsumoto NP, Yuan J, Wang J, Shen Q, Chen X, Kim Y, Zuppan CW, Chang CC, Cui W, Chen D, Shi M, Gisriel SD, Chen M, Xu ML, Pan Z (2022) Mast cell sarcoma: clinicopathologic and molecular analysis of 10 new cases and review of literature. Mod Pathol 35:865–874. https://doi.org/10.1038/s41379-022-01014-w
doi: 10.1038/s41379-022-01014-w pubmed: 35105959
Leguit RJ, Wang SA, George TI, Tzankov A, Orazi A (2023) The international consensus classification of mastocytosis and related entities. Virchows Arch 482:99–112. https://doi.org/10.1007/s00428-022-03423-3
doi: 10.1007/s00428-022-03423-3 pubmed: 36214901
Weiler CR, Butterfield J (2014) Mast cell sarcoma: clinical management. Immunol Allergy Clin North Am 34:423–432. https://doi.org/10.1016/j.iac.2014.01.004
doi: 10.1016/j.iac.2014.01.004 pubmed: 24745684
Monnier J, Georgin-Lavialle S, Canioni D, Lhermitte L, Soussan M, Arock M, Bruneau J, Dubreuil P, Bodemer C, Chandesris MO, Lortholary O, Hermine O, Damaj G (2016) Mast cell sarcoma: new cases and literature review. Oncotarget 7:66299–66309. https://doi.org/10.18632/oncotarget.11812
doi: 10.18632/oncotarget.11812 pubmed: 27602777 pmcid: 5323235
Kharoubi S (2021) Mast cell carcinoma of maxillary sinus. J Otolaryngol Head Neck Dis 3:1–2. https://doi.org/10.5281/zenodo.5145289
doi: 10.5281/zenodo.5145289
Agaimy A, Franchi A, Lund VJ, Skálová A, Bishop JA, Triantafyllou A, Andreasen S, Gnepp DR, Hellquist H, Thompson LDR, Rinaldo A, Ferlito A (2020) Sinonasal undifferentiated carcinoma (SNUC): from an entity to morphologic pattern and back again-a historical perspective. Adv Anat Pathol 27:51–60. https://doi.org/10.1097/pap.0000000000000258
doi: 10.1097/pap.0000000000000258 pubmed: 31876536
Bell D (2024) Top IHC/ISH hacks for and molecular surrogates of poorly differentiated sinonasal small round cell tumors. Head Neck Pathol 18:2. https://doi.org/10.1007/s12105-023-01608-z
doi: 10.1007/s12105-023-01608-z pubmed: 38315310 pmcid: 10844182
Juhlin CC, Bal M (2023) Top 10 histological mimics of neuroendocrine carcinoma you should not miss in the head and neck. Head Neck Pathol 17:66–84. https://doi.org/10.1007/s12105-022-01521-x
doi: 10.1007/s12105-022-01521-x pubmed: 36941503 pmcid: 10063750
Ryan RJ, Akin C, Castells M, Wills M, Selig MK, Nielsen GP, Ferry JA, Hornick JL (2013) Mast cell sarcoma: a rare and potentially under-recognized diagnostic entity with specific therapeutic implications. Mod Pathol 26:533–543. https://doi.org/10.1038/modpathol.2012.199
doi: 10.1038/modpathol.2012.199 pubmed: 23196796
Raymond LM, Funk T, Braziel RM, Fan G, Gatter K, Loriaux M, Dunlap J, Raess PW (2020) Mast cell sarcoma with concurrent mast cell leukaemia. Br J Haematol 189:e160–e164. https://doi.org/10.1111/bjh.16581
doi: 10.1111/bjh.16581 pubmed: 32242922
Sotlar K, Cerny-Reiterer S, Petat-Dutter K, Hessel H, Berezowska S, Müllauer L, Valent P, Horny HP (2011) Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis. Mod Pathol 24:585–595. https://doi.org/10.1038/modpathol.2010.224
doi: 10.1038/modpathol.2010.224 pubmed: 21186345
Russano de Paiva Silva G, Tournier E, Sarian LO, Bulai-Livideanu C, Delsol G, Lamant L, Vassallo J, Brousset P, Laurent C (2018) Prevalence of CD30 immunostaining in neoplastic mast cells: a retrospective immunohistochemical study. Med (Baltim) 97:e10642. https://doi.org/10.1097/md.0000000000010642
doi: 10.1097/md.0000000000010642
Morgado JM, Perbellini O, Johnson RC, Teodósio C, Matito A, Álvarez-Twose I, Bonadonna P, Zamò A, Jara-Acevedo M, Mayado A, Garcia-Montero A, Mollejo M, George TI, Zanotti R, Orfao A, Escribano L, Sánchez-Muñoz L (2013) CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis. Histopathology 63:780–787. https://doi.org/10.1111/his.12221
doi: 10.1111/his.12221 pubmed: 24111625

Auteurs

Tzu-Chien Cheng (TC)

Division of Pathology, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan.

Jim-Ray Chen (JR)

Division of Pathology, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan.

Ren-Ching Wang (RC)

Department of Pathology, China Medical University Hospital, Taichung, Taiwan.

Kung-Chao Chang (KC)

Department of Pathology, College of Medicine, National Cheng Kung University Hospital, National Cheng Kung University, Tainan, Taiwan.

Jen-Fan Hang (JF)

Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shipai Rd, Taipei City, 112201, Taiwan. jfhang@vghtpe.gov.tw.
Department of Pathology, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. jfhang@vghtpe.gov.tw.
Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. jfhang@vghtpe.gov.tw.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH